Dr. Asif Cochinwala
Claim this profilePioneer Research Solutions, Inc.
Studies Arthritis
Studies Rheumatoid Arthritis
3 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Asif Cochinwala is currently running
Litifilimab
for Lupus
In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE). The study will focus on participants who have active disease and are already taking standard of care medications. These may include antimalarials, steroids, and immunosuppressants. The main objective of the study is to learn about the effect litifilimab has on lowering the activity of the disease. The main question researchers want to answer is: - How many participants have an improvement in their symptoms after 52 weeks of treatment? Researchers will answer this and other questions by measuring the symptoms of SLE over time using a variety of scoring tools. These include the SLE Responder Index (SRI), the Systemic Lupus Erythematosus Disease Activity Index-2000 (SLEDAI-2K), and the Patient Global Assessment - Visual Analog Scale (PGA-VAS). Researchers will also learn more about the safety of litifilimab. They will study how participants' immune systems respond to litifilimab. Additionally, they will measure the effect litifilimab and SLE have on the quality of life of participants using a group of questionnaires. The study will be done as follows: After screening, participants will be randomized to receive either a high or low dose of litifilimab, or placebo. A placebo looks like the study drug but contains no real medicine. All participants will receive either litifilimab or placebo as injections under the skin once every 4 weeks. The treatment period will last 52 weeks. Participants will continue to take their standard of care medications. Neither the researchers nor the participants will know if the participants are receiving litifilimab or placebo. There will be a follow-up safety period that lasts up to 24 weeks. In total, participants will have up to 22 study visits. The total study duration for participants will be up to 80 weeks.
Recruiting1 award Phase 3
Baricitinib
for Rheumatoid Arthritis
This trial compares the safety of two treatments for rheumatoid arthritis, focusing on the risk of blood clots. One treatment is baricitinib, an oral medication used for moderate to severe cases.
Recruiting3 awards Phase 43 criteria
More about Asif Cochinwala
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Asif Cochinwala has experience with
- Baricitinib
- TNF Inhibitor
- Olokizumab
- BIIB059 (litifilimab)
- Placebo
Breakdown of trials Asif Cochinwala has run
Arthritis
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Asif Cochinwala specialize in?
Asif Cochinwala focuses on Arthritis and Rheumatoid Arthritis. In particular, much of their work with Arthritis has involved treating patients, or patients who are undergoing treatment.
Is Asif Cochinwala currently recruiting for clinical trials?
Yes, Asif Cochinwala is currently recruiting for 2 clinical trials in Cypress Texas. If you're interested in participating, you should apply.
Are there any treatments that Asif Cochinwala has studied deeply?
Yes, Asif Cochinwala has studied treatments such as Baricitinib, TNF Inhibitor, Olokizumab.
What is the best way to schedule an appointment with Asif Cochinwala?
Apply for one of the trials that Asif Cochinwala is conducting.
What is the office address of Asif Cochinwala?
The office of Asif Cochinwala is located at: Pioneer Research Solutions, Inc., Cypress, Texas 77429 United States. This is the address for their practice at the Pioneer Research Solutions, Inc..
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.